TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
SH2B3 |
Q9UQQ2
|
SH2B adaptor protein 3
|
|
1.0E-04 |
0.527 |
0.692 |
HFE |
Q30201
|
homeostatic iron regulator
|
|
2.6E-08 |
0.436 |
0.846 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HECTD4 |
Q9Y4D8
|
HECT domain E3 ubiquitin protein ligase 4
|
|
1.00 |
0.700 |
0.462 |
LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |
POU5F1 |
Q01860
|
POU class 5 homeobox 1
|
|
0.95 |
0.441 |
0.846 |
HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
CHURC1-FNTB |
P49356
|
CHURC1-FNTB readthrough
|
|
5.3E-05 |
|
|
HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
GLIS3 |
Q8NEA6
|
GLIS family zinc finger 3
|
|
5.6E-08 |
0.590 |
0.654 |
LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
BRAP |
Q7Z569
|
BRCA1 associated protein
|
|
3.8E-06 |
0.612 |
0.769 |
MAPT-AS1 |
|
MAPT antisense RNA 1
|
|
|
0.711 |
0.269 |
USP8P1 |
|
USP8 pseudogene 1
|
|
|
0.805 |
0.269 |
TRIM10 |
Q9UDY6
|
tripartite motif containing 10
|
|
3.7E-09 |
0.821 |
0.269 |
MAPT |
P10636
|
microtubule associated protein tau
|
|
6.0E-03 |
0.446 |
0.923 |
PSORS1C3 |
|
psoriasis susceptibility 1 candidate 3
|
|
|
0.769 |
0.269 |
LINC02210 |
|
long intergenic non-protein coding RNA 2210
|
|
|
0.861 |
0.154 |
MARCHF8 |
Q5T0T0
|
membrane associated ring-CH-type finger 8
|
|
5.9E-07 |
0.590 |
0.692 |